<DOC>
	<DOCNO>NCT01054976</DOCNO>
	<brief_summary>This study examine whether administration galantamine effective improvement attention effective patient serious disturbance attention administer galantamine patient Alzheimer 's dementia perform attention test baseline , week 4 12 .</brief_summary>
	<brief_title>The Efficacy Galantamine Treatment Attention Patients With Alzheimer 's Disease</brief_title>
	<detailed_description>This open label ( people know identity intervention ) , multi-center , prospective study investigate effect galantamine attention Alzheimer 's dementia patient . The objective study include evaluation relationship change attention 4 week galantamine administration investigate effect study drug 12 week administration ( difference improvement attention administration galantamine ) . The secondary objective study clarify causal relationship improvement attention activity daily live ( ADL ) . The design study prospective , open-label , multi-center study . Study population probable Alzheimer 's dementia patient diagnose NINCDS-ADRDA ( National Institute Neurological Communicative Disorders Stroke Alzheimer 's disease Related Disorders Association ) , DSM-IV ( Diagnostic Statistical Manual Mental Disorders ) criterion . The efficacy study drug assess evaluate cognitive function , attention behavioral symptom treatment use follow assessment tool : ADAS-K-cog11 ( Alzheimer 's Disease Assessment Scale - cognitive subscale ) , computerized attention test activity daily live . Safety evaluation include adverse event monitor clinical lab test . The patient administer oral galantamine 8 mg/day first 4 week 16 mg/day . The dose galantamine increase 24 mg tolerate .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>Alzheimer 's disease accord criterion DSMIV , NINCDSADRDA KMMSE ( Korean Mini Mental State Exam ) 10 24 Reliable Guardian available patient Patient guardian provide write informed consent enter clinical trial Acetylcholine esterase inhibitor use treat dementia take within 30 day begin clinical trial Neurodegenerative disease ( eg Parkinson 's disease , Pick 's disease , Huntington 's disease , Down syndrome ) Dementia relate head trauma dementia relate brain damage due cerebral hypoxia ( hypoxic brain damage cardiopulmonary resuscitation , hypoxic brain damage surgery , hypoxic brain damage due addiction , hypoxic brain damage due shock ) brain tumor , nerve syphilis , meningitis , encephalitis epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Galantamine</keyword>
	<keyword>Dementia</keyword>
</DOC>